Carbapenem-resistant Enterobacteriaceae (CRE) is a family of bacteria that have developed genetic mutations which enable them to withstand treatments with commonly used antibiotics. This includes Carbapenems, a powerful class of drugs used to treat serious infections. During the last few decades, CRE has been detected in an increasing number of hospital settings worldwide. Due to their ability to spread rapidly, these bacteria have become a huge threat to human health and are considered an urgent health concern by the World Health Organization.
Table of Contents
What is Carbapenem-resistant enterobacteriaceae
Carbapenem-resistant Enterobacteriaceae (CRE) is a family of bacteria that are resistant to all or the most available antibiotics. CRE has the potential to pose a significant public health threat because certain CRE strains can cause multidrug-resistant infections that are difficult to treat and may be fatal. Infection with CRE can lead to serious complications, such as sepsis, organ failure, and even death. To make matters worse, CRE is highly contagious and can spread rapidly in healthcare settings, particularly those that don’t practice proper sanitation and hygiene protocols.
This is a type of bacteria that is resistant to carbapenem antibiotics. These bacteria have been identified as a serious global threat due to their ability to spread quickly and cause severe infections at healthcare facilities across the world. CRE infections have a mortality rate of up to 50%, making them particularly deadly. Additionally, CREs can travel between countries, leading to even more serious outbreaks of these dangerous bacteria.
Symptoms for CRE
Carbapenem-resistant enterobacteriaceae (CRE) is a type of bacteria that is resistant to the carbapenem class of antibiotics, which are often used as a last resort for treating infections caused by other antibiotic-resistant bacteria. CRE infections can be difficult to treat because the bacteria are resistant to many antibiotics.
Symptoms of a CRE infection may vary depending on the specific type of infection and the part of the body that is affected. In general, symptoms of a CRE infection may include:
Fever
Chills
Nausea and vomiting
Diarrhea
Abdominal pain
Blood in the stool
Chest pain (if the infection is in the lungs)
Difficulty breathing (if the infection is in the lungs)
If you think you may have a CRE infection, it is important to seek medical attention as soon as possible. Your healthcare provider can perform tests to confirm the diagnosis and recommend the appropriate treatment.
Causes for Carbapenem-resistant enterobacteriaceae
Carbapenem-resistant enterobacteriaceae (CRE) are bacteria that are resistant to the carbapenem class of antibiotics. These antibiotics are often used as a last resort for treating infections caused by other antibiotic-resistant bacteria. CRE infections can be difficult to treat because the bacteria are resistant to many antibiotics.
CRE bacteria are found in healthcare settings, such as hospitals and nursing homes, where they can spread from person to person through contact with contaminated surfaces or equipment. People who are hospitalized or who have weakened immune systems, such as those with cancer or HIV, are at higher risk of getting a CRE infection.
CRE infections may also occur in people who have recently taken antibiotics or who have a medical device, such as a catheter or breathing tube, inserted into their body. Using antibiotics improperly, such as not finishing the full course of treatment or using them to treat a viral infection, can also contribute to the development of antibiotic-resistant bacteria like CRE.
Treatment
Treatment for carbapenem-resistant enterobacteriaceae (CRE) infections can be challenging because the bacteria are resistant to many antibiotics. If you have a CRE infection, your healthcare provider will work with you to develop a treatment plan that is appropriate for your specific situation.
Possible treatments for a CRE infection may include:
Antibiotics: If a CRE infection is suspected, your healthcare provider may start treatment with a combination of antibiotics. The specific antibiotics used will depend on the type of infection and the susceptibility of the bacteria to certain antibiotics.
Supportive care: If you have a CRE infection, you may need supportive care to help manage your symptoms and prevent complications. This may include fluids to help prevent dehydration, pain medication to help manage pain, and oxygen therapy if you are having difficulty breathing.
Infection prevention measures: To help prevent the spread of a CRE infection, your healthcare provider may recommend infection prevention measures, such as washing your hands frequently, cleaning contaminated surfaces and equipment, and wearing gloves and other protective equipment.
It is important to follow your healthcare provider’s instructions and complete the full course of treatment as prescribed to help clear the infection and prevent the development of antibiotic-resistant bacteria.
Conclusion
Carbapenem-resistant Enterobacteriaceae (CRE) is a group of bacteria that have developed a high level of resistance to antibiotics referred to as the “last line of defense” when fighting infections. This family of bacteria is known for its ability to spread and impact anyone regardless of age, gender, or medical history. Although certain antibiotics can be used to treat CRE infections, the threat of antibiotic resistance continues to elude the medical and scientific communities at large. As a result, prevention methods have become an invaluable approach to combating the spread of CRE.